Increased NT-proBNP levels have been presented in fetuses with cardiovascular dysfunctions, such as structural cardiac malformations [11], as well as in fetuses with anemia [6], but also in fetuses with urinary tract malformations [12] or severe growth restriction [13]. This evidence concerns the gene NPPB and anemia (phenotype).